Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis
Authors:
Abstract
No abstract availableKeywords
Funding Information
- DFG (CRC643, SPP1468)
- IMI-BTCure (115142)
- BMBF-METARTHROS (01EC1407A)
- EU-Team (305549)
This publication has 20 references indexed in Scilit:
- Osteoprotection by semaphorin 3ANature, 2012
- Cellular mechanisms of bone remodelingReviews in Endocrine and Metabolic Disorders, 2010
- Cellular communications in bone homeostasis and repairCellular and Molecular Life Sciences, 2010
- Bidirectional ephrinB2-EphB4 signaling controls bone homeostasisCell Metabolism, 2006
- Galectin-3: An open-ended storyBiochimica et Biophysica Acta (BBA) - General Subjects, 2006
- Osteoclast differentiation and activationNature, 2003
- God must love galectins; He made so many of themGlycobiology, 1999
- A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and FunctionBiochemical and Biophysical Research Communications, 1999
- OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisNature, 1999
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997